O'Shaughnessy Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-46,178	Closed	-$261K	–	2265
2020 Q3	$261K	Sell	46,178 -12,800	-22%	-$61K	0.01%	621
2020 Q2	$301K	Sell	58,978 -10,088	-15%	-$42K	0.01%	533
2020 Q1	$239K	Buy	+69,066	New	+$404K	0.01%	427
2018 Q4	–	Sell	-15,057	Closed	-$36K	–	1044
2018 Q3	$36K	Sell	15,057 -8,661	-37%	-$21.6K	﹤0.01%	732
2018 Q2	$65K	Sell	23,718 -8,623	-27%	-$23.8K	﹤0.01%	690
2018 Q1	$89K	Buy	+32,341	New	+$93.7K	﹤0.01%	649

Other funds holding ISEE

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

O'Shaughnessy Asset Management's ISEE Position: Q4 2020 in Review

O'Shaughnessy Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2020, closing a stake of 46,178 shares — an estimated $261K sold.

O'Shaughnessy Asset Management first reported a position in ISEE in Q1 2018 and held it in 6 quarters. The position peaked at $301K in Q2 2020. 120 funds tracked by Wall St. Rank hold ISEE as of Q4 2020.

O'Shaughnessy Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
O'Shaughnessy Asset Management sold 46,178 IVERIC bio, Inc. Common Stock shares in Q4 2020, an estimated $261K.
O'Shaughnessy Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2018 and held it in 6 quarters.
O'Shaughnessy Asset Management's IVERIC bio, Inc. Common Stock position peaked at $301K in Q2 2020.
120 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2020.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.